These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19175915)

  • 1. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure.
    Parés A; Deulofeu R; Cisneros L; Escorsell A; Salmerón JM; Caballería J; Mas A
    Crit Care; 2009; 13(1):R8. PubMed ID: 19175915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy.
    Koivusalo AM; Teikari T; Höckerstedt K; Isoniemi H
    Metab Brain Dis; 2008 Dec; 23(4):387-98. PubMed ID: 18773287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma amino acids in hepatic encephalopathy.
    Ferenci P; Wewalka F
    J Neural Transm Suppl; 1978; (14):87-94. PubMed ID: 290744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS).
    Loock J; Mitzner SR; Peters E; Schmidt R; Stange J
    Liver; 2002; 22 Suppl 2():35-9. PubMed ID: 12220301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal liver support in severe alcoholic hepatitis.
    Parés A; Mas A
    World J Gastroenterol; 2014 Jul; 20(25):8011-7. PubMed ID: 25009371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.
    Sen S; Mookerjee RP; Cheshire LM; Davies NA; Williams R; Jalan R
    J Hepatol; 2005 Jul; 43(1):142-8. PubMed ID: 15878216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powdered sorbent liver dialysis and pheresis in treatment of hepatic failure.
    Ash SR
    Ther Apher; 2001 Oct; 5(5):404-16. PubMed ID: 11778927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle metabolism and whole blood amino acid profile in patients with liver disease.
    Dam G; Sørensen M; Buhl M; Sandahl TD; Møller N; Ott P; Vilstrup H
    Scand J Clin Lab Invest; 2015; 75(8):674-80. PubMed ID: 26243157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.
    Ash SR
    Adv Ren Replace Ther; 2002 Jan; 9(1):3-18. PubMed ID: 11927902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Amino Acid Concentrations Predict Mortality in Patients with End-Stage Liver Disease.
    Kinny-Köster B; Bartels M; Becker S; Scholz M; Thiery J; Ceglarek U; Kaiser T
    PLoS One; 2016; 11(7):e0159205. PubMed ID: 27410482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements.
    Lesesne HR; Bozymski EM; Fallon HJ
    Gastroenterology; 1978 Feb; 74(2 Pt 1):169-73. PubMed ID: 340319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure.
    Kobashi-Margáin RA; Gavilanes-Espinar JG; Gutiérrez-Grobe Y; Gutiérrez-Jiménez AA; Chávez-Tapia N; Ponciano-Rodríguez G; Uribe M; Méndez Sánchez N
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S70-6. PubMed ID: 22228886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma amino acids during extracorporeal liver support by fractionated plasma separation and adsorption.
    Rifai K; Das A; Rosenau J; Ernst T; Kretschmer U; Haller H; Fliser D; Manns MP
    Artif Organs; 2010 Feb; 34(2):166-70. PubMed ID: 19817727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin Dialysis for Liver Failure: A Systematic Review.
    Tsipotis E; Shuja A; Jaber BL
    Adv Chronic Kidney Dis; 2015 Sep; 22(5):382-90. PubMed ID: 26311600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
    Mitzner SR
    Ann Hepatol; 2011 May; 10 Suppl 1():S21-8. PubMed ID: 21566251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Pass Albumin Dialysis in the Treatment of Children with Liver Failure.
    Holle J; Gratopp A; Balmer S; Varnholt V; Henning S; Bufler P; Müller D; Rosenfeld L
    Blood Purif; 2020; 49(1-2):55-62. PubMed ID: 31527371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sorbent suspension dialysis on plasma amino acid levels in cirrhotic patients with refractory hepatic encephalopathy.
    Bauer E; Gendo A; Madl C; Garo F; Roth E; Kramer L
    Int J Artif Organs; 2002 Oct; 25(10):923-8. PubMed ID: 12456032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior reversible encephalopathy syndrome in alcoholic hepatitis: Hepatic encephalopathy a common theme.
    John ES; Sedhom R; Dalal I; Sharma R
    World J Gastroenterol; 2017 Jan; 23(2):373-376. PubMed ID: 28127211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.